IHT Wealth Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-12,577
Closed -$271K 1064
2023
Q4
$271K Buy
+12,577
New +$232K 0.01% 806
2022
Q3
Sell
-6,354
Closed -$211K 907
2022
Q2
$211K Buy
6,354
+684
+12% +$29.1K 0.02% 650
2022
Q1
$409K Sell
5,670
-56
-1% -$4.03K 0.03% 478
2021
Q4
$526K Buy
5,726
+1,299
+29% +$155K 0.04% 421
2021
Q3
$561K Buy
4,427
+734
+20% +$107K 0.05% 393
2021
Q2
$614K Sell
3,693
-1,537
-29% -$249K 0.04% 458
2021
Q1
$951K Buy
5,230
+2,436
+87% +$565K 0.07% 277
2020
Q4
$559K Buy
+2,794
New +$568K 0.05% 371
2020
Q3
Sell
-1,986
Closed -$379K 691
2020
Q2
$379K Buy
1,986
+309
+18% +$54.2K 0.05% 351
2020
Q1
$260K Buy
+1,677
New +$195K 0.04% 431
2018
Q2
Sell
-24
Closed -$1K 1254
2018
Q1
$1K Hold
24
﹤0.01% 1631
2017
Q4
$1K Hold
24
﹤0.01% 1625
2017
Q3
$1K Buy
+24
New +$787 ﹤0.01% 1356

Other funds holding TDOC

IHT Wealth Management's TDOC Position: Q1 2024 in Review

IHT Wealth Management sold out of Teladoc Health (TDOC) in Q1 2024, closing a stake of 12,577 shares — an estimated $271K sold.

IHT Wealth Management first reported a position in TDOC in Q3 2017 and held it in 13 quarters. The position peaked at $951K in Q1 2021. 426 funds tracked by Wall St. Rank hold TDOC as of Q1 2024.

  • IHT Wealth Management reported no remaining Teladoc Health position as of Q1 2024 after selling out during the quarter.
  • IHT Wealth Management sold 12,577 Teladoc Health shares in Q1 2024, an estimated $271K.
  • IHT Wealth Management first reported a position in Teladoc Health in Q3 2017 and held it in 13 quarters.
  • IHT Wealth Management's Teladoc Health position peaked at $951K in Q1 2021.
  • 426 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2024.

Based on IHT Wealth Management's 13F filing for Q1 2024, filed 15 May 2024.